Yingzhu Li

发表

Association between Serum Potassium with Risk of Onset and Visual Field Progression in Patients with Primary Angle Close Glaucoma: A Cross-Sectional and Prospective Cohort Study

Xinghuai Sun, Jiaojiao Wei, W. Cao, 2022, Oxidative medicine and cellular longevity.

Association between 17-β-estradiol and IL-8 and visual field progression in postmenopausal women with primary angle closure glaucoma.

Xinghuai Sun, Haichen Zhang, W. Cao, 2020, American journal of ophthalmology.

Association of systemic inflammation indices with visual field loss progression in patients with primary angle-closure glaucoma: potential biomarkers for 3P medical approaches

Xinghuai Sun, W. Cao, Shengjie Li, 2021, EPMA Journal.

Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma

Xinghuai Sun, W. Cao, Shengjie Li, 2022, British Journal of Ophthalmology.

Effects of novel diabetic therapeutic footwear on preventing ulcer recurrence in patients with a history of diabetic foot ulceration: study protocol for an open-label, randomized, controlled trial

Guanjian Liu, X. Ran, Chun Wang, 2021, Trials.

Relationship between Oxidative Stress Biomarkers and Visual Field Progression in Patients with Primary Angle Closure Glaucoma

Xinghuai Sun, W. Cao, Shengjie Li, 2020, Oxidative medicine and cellular longevity.

Association Between Serum Lipid Levels and Patients With Primary Angle-Closure Glaucoma in China: A Cross Sectional, Case–Control Study

W. Cao, Shengjie Li, M. Shao, 2021, Frontiers in Medicine.

Development and validation of a routine blood parameters-based model for screening the occurrence of retinal detachment in high myopia in the context of PPPM

Meiyan Li, W. Cao, Shengjie Li, 2023, EPMA Journal.

Metabolomics Identifies and Validates Serum Novel Biomarker for Diagnosing Primary Angle Closure Glaucoma and Predicting the Visual Field Progression

Xinghuai Sun, W. Cao, Shengjie Li, 2023, medRxiv.

Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression

W. Cao, Shengjie Li, M. Shao, 2024, eLife.